Presentation AHA 2024 Efficacy and safety of EdoxabaN in anticoagulant therapy after surgical Bioprosthetic vALVe replacement Presenter: Chisato Izumi November 17, 2024
News Conference News AHA 2024 ENBALV: Edoxaban Matches Warfarin After Bioprosthetic Valve Surgery Yael L. Maxwell November 17, 2024
News Opinion Editor's Corner AHA 2021 AHA 2021 Tackles AF Triggers, Watchful Waiting in AS, Data Overload, and More Shelley Wood November 08, 2021
News Conference News AHA 2017 More Support for TMVR After Failed Mitral Bioprostheses Yael L. Maxwell November 23, 2017
News Conference News AHA 2015 At 2 Years, Surgical Valve Replacement Still Beats Repair in Severe Mitral Regurgitation L.A. McKeown November 08, 2015
News Conference News AHA 2013 AHA 2013: Mix of Positive, Negative Trials Help Guide Interventional Practice November 24, 2013
News Conference News AHA 2013 Similar Long-term Benefits With Mitral Valve Repair, Replacement for Ischemic MR Yael L. Maxwell November 19, 2013